» Articles » PMID: 4548834

In Vitro Susceptibility of Haemophilus Influenzae to Trimethoprim-sulfamethoxazole

Overview
Specialty Pharmacology
Date 1974 Dec 1
PMID 4548834
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty-four strains of Haemophilus influenzae (20 ampicillin sensitive and 14 ampicillin resistant), mostly type b isolates from cerebrospinal fluid or blood, were tested for susceptibility to a combination of trimethoprim-sulfamethoxazole (TMP-SMZ) in a ratio of 1 part TMP to 19 parts SMZ. All strains were very susceptible to the TMP-SMZ combination, with minimal inhibitory concentrations ranging from 0.007-0.14 to 0.06-1.18 mug of TMP-SMZ per ml. There was little difference in the susceptibility of the ampicillin-sensitive and ampicillin-resistant strains to TMP-SMZ.

Citing Articles

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Fuchs P, Barry A, Brown S J Clin Microbiol. 1997; 35(1):125-31.

PMID: 8968893 PMC: 229524. DOI: 10.1128/jcm.35.1.125-131.1997.


Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System.

Baker C, Thornsberry C, Hawkinson R J Clin Microbiol. 1983; 17(3):450-7.

PMID: 6841581 PMC: 272664. DOI: 10.1128/jcm.17.3.450-457.1983.


Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.

Fass R, Helsel V Eur J Clin Microbiol. 1984; 3(4):318-9.

PMID: 6489321 DOI: 10.1007/BF01977481.


Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Jorgensen J, REDDING J, Maher L, Howell A J Clin Microbiol. 1987; 25(11):2105-13.

PMID: 3500965 PMC: 269421. DOI: 10.1128/jcm.25.11.2105-2113.1987.


Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.

Bergeron M, Simard P, Provencher P J Clin Microbiol. 1987; 25(4):650-5.

PMID: 3494745 PMC: 266053. DOI: 10.1128/jcm.25.4.650-655.1987.


References
1.
GARROD L . The possible scope of trimethoprim-sulphonamide treatment. Postgrad Med J. 1969; 45:Suppl:52-5. View

2.
May J, Davies J . Resistance of Haemophilus influenzae to trimethoprim. Br Med J. 1972; 3(5823):376-7. PMC: 1785450. DOI: 10.1136/bmj.3.5823.376. View

3.
Bushby S . Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973; 128:Suppl:442-62 p. DOI: 10.1093/infdis/128.supplement_3.s442. View

4.
Bach M, FINLAND M, GOLD O, Wilcox C . Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. J Infect Dis. 1973; 128:Suppl:508-33 p. DOI: 10.1093/infdis/128.supplement_3.s508. View

5.
FINLAND M, KASS E . Trimethoprim-sulfamethoxazole. Summary and comments on the conference. J Infect Dis. 1973; 128:Suppl:792-816. DOI: 10.1093/infdis/128.supplement_3.s792. View